Insulet Corp: Form 10-Q for the period ended Sep 30, 2017
Filed with the SEC on Nov 3, 2017 and accepted by EDGAR at Nov 2, 2017, 18:16 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2017-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Cost of revenue | 3 months2017-07-01 to 2017-09-30 | $48.2m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2017-01-01 to 2017-09-30 | $135.6m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2017-07-01 to 2017-09-30 | $73.6m | us-gaap:GrossProfit |
| Gross profit | 9 months2017-01-01 to 2017-09-30 | $197.7m | us-gaap:GrossProfit |
| Research and development | 3 months2017-07-01 to 2017-09-30 | $20.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 9 months2017-01-01 to 2017-09-30 | $55.7m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2017-07-01 to 2017-09-30 | $2.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2017-01-01 to 2017-09-30 | −$6.6m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2017-07-01 to 2017-09-30 | $121.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2017-01-01 to 2017-09-30 | $318.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2017-07-01 to 2017-09-30 | −$2.2m | us-gaap:NetIncomeLoss |
| Net income | 9 months2017-01-01 to 2017-09-30 | −$20.0m | us-gaap:NetIncomeLoss |
| Operating cash flow | 9 months2017-01-01 to 2017-09-30 | $19.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 9 months2017-01-01 to 2017-09-30 | $47.8m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | At period end2017-09-30 | $102.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2017-09-30 | $366.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2017-09-30 | $500.3m | us-gaap:Assets |
| Current liabilities | At period end2017-09-30 | $74.9m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2017-09-30 | $426.1m | us-gaap:Liabilities |
| Long-term debt | At period end2017-09-30 | $345.0m | us-gaap:LongTermDebtNoncurrent |
| Shareholders' equity | At period end2017-09-30 | $74.3m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001145197-17-000017. Last ingested by Listed: Nov 14, 2026, 12:01 ET. Listed shows no prices and gives no investment advice.